SRR1479510
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- SPERMATOGENESIS+0.262
- KRAS_SIGNALING_DN+0.133
- DNA_REPAIR+0.126
- OXIDATIVE_PHOSPHORYLATION+0.092
- MYC_TARGETS_V2+0.057
- MITOTIC_SPINDLE-0.015
- MYC_TARGETS_V1-0.026
- WNT_BETA_CATENIN_SIGNALING-0.064
- APICAL_JUNCTION-0.083
- UV_RESPONSE_UP-0.086
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.636
- INFLAMMATORY_RESPONSE-0.552
- INTERFERON_GAMMA_RESPONSE-0.532
- TNFA_SIGNALING_VIA_NFKB-0.531
- IL6_JAK_STAT3_SIGNALING-0.518
- ALLOGRAFT_REJECTION-0.499
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.499
- COAGULATION-0.489
- ANGIOGENESIS-0.470
- TGF_BETA_SIGNALING-0.447
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1456531 | GTEX | — | 0.984 |
| 2 | SRR1464305 | GTEX | — | 0.984 |
| 3 | SRR1490568 | GTEX | — | 0.983 |
| 4 | SRR1499982 | GTEX | — | 0.982 |
| 5 | SRR1398992 | GTEX | — | 0.981 |
| 6 | SRR1348770 | GTEX | — | 0.980 |
| 7 | SRR1360038 | GTEX | — | 0.979 |
| 8 | SRR1356204 | GTEX | — | 0.977 |
| 9 | SRR1456514 | GTEX | — | 0.977 |
| 10 | SRR1359367 | GTEX | — | 0.976 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 5 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| SPERMATOGENESIS | 0.262 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.133 | Remibrutinib | — uncovered |
| DNA_REPAIR | 0.126 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.092 | Remibrutinib | — uncovered |
| MYC_TARGETS_V2 | 0.057 | Idelalisib | — uncovered |